Back to News
Feb 23, 2026 8:01 AM

Earnings Breakdown: ImmunityBio Q4

ImmunityBio (NASDAQ:IBRX) released its Q4 earnings on Monday, February 23, 2026 at 07:00 AM.

Here's what's important from the earnings announcement.

Earnings

ImmunityBio beat estimated earnings by 33.33%, reporting an EPS of $-0.06 versus an estimate of $-0.09.

Revenue was up $30.73 million from the same period last year.

Overview of Past Earnings

The company beat on EPS by $0.03 in the last quarter, ...